FDA Authorizes Rutgers Saliva Test for Coronavirus
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read MorePosted by | Apr 16, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Based on CDC guidelines, the guidance will help ensure infection control in a variety of patient settings.
Read MorePosted by | Apr 15, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
No instrumentation or trained personnel would be needed to administer the test or to read the results.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
CQuentia’s covid-19 assay has received FDA emergency use authorization, and its lab has the capacity to process more than 20,000 samples per month.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
End-to-end testing enables Fulgent to more efficiently manage the demand it is seeing for both its RT-PCR and next-generation sequencing tests for Covid-19.
Read More